Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Allergy and Asthma Proceedings|November 24, 2007
Levocetirizine and cytokine production and apoptosis of human eosinophilsHannele Hasala, Mirkka Janka-Junttila, Eeva Moilanen, et al.Pulmonary Pharmacology & Therapeutics|August 29, 2006
c-Jun N-terminal kinase mediates constitutive human eosinophil apoptosisHannele Hasala, Xianzhi Zhang, Seppo Saarelainen, et al.Pulmonary Pharmacology & Therapeutics|December 17, 2008
Bacterial DNA delays human eosinophil apoptosisPinja Ilmarinen, Hannele Hasala, Outi Sareila, et al.Pulmonary Pharmacology & Therapeutics|February 20, 2008
Phosphodiesterase 4 inhibitors delay human eosinophil and neutrophil apoptosis in the absence and presence of salbutamolJouni Parkkonen, Hannele Hasala, Eeva Moilanen, et al.Journal of Cell Death|October 9, 2015
Dexamethasone and RU24858 Induce Survival and Growth Factor Receptor Bound Protein 2, Leukotriene B4 Receptor 1 and Annexin-1 Expression in Primary Human NeutrophilsMirkka Janka-Junttila, Hannele Hasala, Ian Adcock, et al.Pulmonary Pharmacology & Therapeutics|May 8, 2007
Histamine reverses IL-5-afforded human eosinophil survival by inducing apoptosis: pharmacological evidence for a novel mechanism of action of histamineHannele Hasala, Mark A Giembycz, Mirkka Janka-Junttila, et al.Allergy and Asthma Proceedings|March 30, 2007
First-generation antihistamines diphenhydramine and chlorpheniramine reverse cytokine-afforded eosinophil survival by enhancing apoptosisHannele Hasala, Eeva Moilanen, Mirkka Janka-Junttila, et al.Journal of Inflammation (London, England)|July 13, 2006
The glucocorticoid RU24858 does not distinguish between transrepression and transactivation in primary human eosinophilsMirkka Janka-Junttila, Eeva Moilanen, Hannele Hasala, et al.European Clinical Respiratory Journal|March 23, 2023
Virtual communication is commonly used in Finnish interstitial lung disease multidisciplinary meetingsJohanna Salonen, Hanna Nurmi, Ulla Hodgson, et al.Journal of Pain and Symptom Management|September 6, 2025
Management of dyspnea with high-flow nasal air or fan - a randomized controlled crossover trialSirpa Leivo-Korpela, Heidi A Rantala, Lauri Lehtimäki, et al.Pageof 2